CRIS Current Research Information System

LEWIS, RUSSEL EDWARD
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.077
AS - Asia 7.096
EU - Europa 5.024
SA - Sud America 551
AF - Africa 428
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 1
Totale 22.203
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.957
VN - Vietnam 2.325
SG - Singapore 1.947
CN - Cina 1.467
GB - Regno Unito 1.432
DE - Germania 717
IT - Italia 711
SE - Svezia 559
HK - Hong Kong 426
FR - Francia 391
BR - Brasile 385
IN - India 357
RU - Federazione Russa 329
IE - Irlanda 223
ZA - Sudafrica 152
EE - Estonia 112
JP - Giappone 101
UA - Ucraina 88
BD - Bangladesh 85
FI - Finlandia 83
NL - Olanda 81
CI - Costa d'Avorio 78
AR - Argentina 72
EG - Egitto 61
BG - Bulgaria 60
CA - Canada 60
PH - Filippine 53
AT - Austria 44
TG - Togo 44
ES - Italia 40
KR - Corea 40
JO - Giordania 36
ID - Indonesia 34
MX - Messico 34
CH - Svizzera 33
IQ - Iraq 32
BE - Belgio 31
TH - Thailandia 30
TR - Turchia 27
CL - Cile 24
EC - Ecuador 24
DZ - Algeria 21
NG - Nigeria 20
AU - Australia 19
PL - Polonia 19
RO - Romania 18
TW - Taiwan 18
PK - Pakistan 16
SC - Seychelles 16
CO - Colombia 15
SA - Arabia Saudita 15
UZ - Uzbekistan 14
LB - Libano 11
LT - Lituania 10
MY - Malesia 10
TN - Tunisia 10
GR - Grecia 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 8
IR - Iran 7
PY - Paraguay 7
CZ - Repubblica Ceca 6
HU - Ungheria 6
IL - Israele 6
DO - Repubblica Dominicana 5
JM - Giamaica 5
KZ - Kazakistan 5
MA - Marocco 5
NP - Nepal 5
PT - Portogallo 5
UY - Uruguay 5
ET - Etiopia 4
HN - Honduras 4
KE - Kenya 4
PE - Perù 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
KG - Kirghizistan 3
KW - Kuwait 3
LI - Liechtenstein 3
LY - Libia 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
BH - Bahrain 2
BY - Bielorussia 2
CR - Costa Rica 2
EU - Europa 2
GT - Guatemala 2
KH - Cambogia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PS - Palestinian Territory 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
Totale 22.180
Salva come PNG Salva come JPEG
Città #
Singapore 1.361
Southend 1.274
Fairfield 1.141
Ashburn 881
San Jose 557
Ho Chi Minh City 533
Woodbridge 485
Wilmington 483
Chandler 479
Hanoi 455
Seattle 419
Houston 418
Hong Kong 401
Cambridge 378
Dong Ket 338
Princeton 319
Ann Arbor 267
Boardman 234
Dublin 222
Santa Clara 220
Beijing 200
Lauterbourg 176
Bologna 162
Westminster 134
Los Angeles 125
Nanjing 116
New York 113
Berlin 105
Padova 96
Dallas 88
Jinan 83
Abidjan 78
Tokyo 77
Shenyang 75
Helsinki 72
Redondo Beach 71
Dearborn 68
Council Bluffs 67
Saint Petersburg 67
Buffalo 66
Da Nang 66
Cairo 58
Sofia 58
Haiphong 56
San Diego 54
Hebei 48
Nanchang 47
Frankfurt am Main 46
Changsha 45
Lomé 44
Guangzhou 42
Nuremberg 42
Shanghai 41
São Paulo 41
Chicago 38
Amman 35
Falls Church 35
Bremen 32
Redmond 32
Yubileyny 30
Brussels 29
Hefei 29
Jiaxing 29
Olalla 28
Quận Bình Thạnh 28
Medford 27
Munich 27
Des Moines 26
Florence 26
Can Tho 25
San Francisco 25
Tianjin 25
Vienna 25
Milan 24
Zhengzhou 24
Biên Hòa 23
Rome 23
Jakarta 22
Ninh Bình 22
Toronto 21
Turin 21
Ha Long 20
Hải Dương 20
Ningbo 19
Abeokuta 18
Phoenix 18
Redwood City 18
Thái Nguyên 18
Bühl 17
Montreal 17
Bern 16
Hangzhou 16
Bangkok 15
Brooklyn 15
Buenos Aires 15
London 15
Vũng Tàu 15
Haikou 14
Johannesburg 14
Kunming 14
Totale 14.637
Salva come PNG Salva come JPEG
Nome #
How I treat mucormycosis 318
Antifungal agents 265
Acute Invasive Fungal Rhinosinusitis in Immunocompromised Patients: Role of an Early Diagnosis 257
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 256
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study 254
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study 252
Carbapenem resistant bacteria in Intensive Care Unit during COVID-19 pandemic: Multicenter before-after cross sectional study 234
Ceftolozane-Tazobactam Treatment of Hypervirulent Multidrug Resistant Pseudomonas aeruginosa Infections in Neutropenic Patients 229
In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment 223
Larger size of donor alloreactive NK cell repertoire correlates with better response to NK cell immunotherapy in elderly acute myeloid leukemia patients 220
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 216
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 215
Pharmacokinetic-pharmacodynamic optimization of triazole antifungal therapy 212
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 208
Beyond biomarkers: How enhanced CT imaging can improve the diagnostic-driven management of invasive mould disease 205
Characterization of antibody response in neuroinvasive infection caused by Toscana virus 201
Donor Natural Killer (NK) Alloreactivity Predicts Long-Term Relapse-Free Survival in Acute Myeloid Leukemia Patients Undergoing Immunotherapy with NK Cells 199
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections 198
Computed tomographic pulmonary angiography for diagnosis of invasive mold diseases in patients with hematological malignancies 196
Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study 193
Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy 191
Early low-dose computed tomography with pulmonary angiography to improve the early diagnosis of invasive mould disease in patients with haematological malignancies: A pilot study 191
Toll-deficient Drosophila are resistant to infection by Pneumocystis spp. Additional evidence of specificity to mammalian hosts 189
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation 188
Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis 183
Saprochaete clavata infections in patients undergoing treatment for haematological malignancies: A report of a monocentric outbreak and review of the literature 181
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 179
Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment 178
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 177
Computerized tomographic pulmonary angiography discriminates invasive mould disease of the lung from lymphoma 176
Successful treatment of bilateral endogenous Fusarium solani endophthalmitis in a patient with acute lymphocytic leukaemia 175
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study 170
Animal Models for Studying Triazole Resistance in Aspergillus fumigatus 168
Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae 168
A risk prediction score for invasive mold disease in patients with hematological malignancies 168
Prognostic utility of the new definition of difficult-to-treat resistance among patients with gram-negative bloodstream infections 165
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 164
Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. 159
In vitro interaction of ceftazidime–avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates 159
Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study 159
Development and internal validation of a model for predicting 60-day risk of invasive mould disease in patients with haematological malignancies 157
Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection after Liver Transplantation: A Multinational Cohort Study 155
Activity of Deferasirox in Mucorales: Influences of Species and Exogenous Iron 154
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 152
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline 150
Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study 148
The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida. 146
Aggressive versus conservative initiation of antibiotics 146
Radiology-based diagnosis of fungal pulmonary infections in high-risk hematology patients: are we making progress? 145
Invasive Mucormycosis. In Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 8th Edition 145
The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study 142
Retrospective cohort analysis of liposomal amphotericin b nephrotoxicity in patients with hematological malignancies 141
Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in Candida spp colonized patients 141
Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation with Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015 140
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant Enterobacterales 140
Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines 140
Development and applications of prognostic risk models in the management of invasive mold disease 140
Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection 139
Anidulafungin versus Caspofungin in a Mouse Model of Candidiasis Caused by Anidulafungin-Susceptible Candida parapsilosis Isolates with Different Degrees of Caspofungin Susceptibility 136
Reply to "Risk for Invasive Fungal Infections during Acute Myeloid Leukemia Induction Therapy: a True Association with Echinocandins?" 134
Mucorales-specific T cells in patients with hematologic malignancies 134
Treatment of MDR-Gram negative infections in the 21st century: a never ending threat for clinicians 133
Serum bactericidal titres for monitoring antimicrobial therapy: current status and potential role in the management of multidrug-resistant Gram-negative infections 132
Comparative in vivo dose-dependent activity of caspofungin and anidulafungin against echinocandin-susceptible and -resistant Aspergillus fumigatus 131
Azole-resistance in Aspergillus terreus and related species: An emerging problem or a rare Phenomenon? 130
Innate inflammatory response and immunopharmacologic activity of micafungin, caspofungin, and voriconazole against wild-type and FKS mutant Candida glabrata isolates 129
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study 127
Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients 127
Serum Galactomannan Diagnosis of Breakthrough Invasive Fungal Disease 126
Antifungal agents:triazoles 126
The role of extended infusion β-lactams in the treatment of bloodstream infections in patients with liver cirrhosis 125
Influence of host immunosuppression on CT findings in invasive pulmonary aspergillosis 124
Comparative Pharmacodynamics of Posaconazole in Neutropenic Murine Models of Invasive Pulmonary Aspergillosis and Mucormycosis 123
Predictors of mortality in multidrug-resistantKlebsiella pneumoniaebloodstream infections 123
Breakthrough invasive mold infections in the hematology patient: Current concepts and future directions 123
Live monitoring and analysis of fungal growth, viability, and mycelial morphology using the incucyte neurotrack processing module 123
Proangiogenic Growth Factors Potentiate In Situ Angiogenesis and Enhance Antifungal Drug Activity in Murine Invasive Aspergillosis 122
Combination Therapy for Mucormycosis: Why, What, and How? 120
Treatment principles for the management of mold infections 120
Efficacy of Caspofungin in Neutropenic and Corticosteroid-Immunosuppressed Murine Models of Invasive Pulmonary Mucormycosis 119
The utility of contrast-enhanced hypodense sign for the diagnosis of pulmonary invasive mold disease in patients with haematological malignancies 119
In vitro interactions among echinocandins against Aspergillus fumigatus: lack of concordance among methods 118
Fitness and Virulence Costs of Candida albicans FKS1 Hot Spot Mutations Associated With Echinocandin Resistance 118
High-dose induction liposomal amphotericin B followed by de-escalation is effective in experimental Aspergillus terreus pneumonia 118
Current Concepts in Antifungal Pharmacology 117
A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study 117
Fungal Drug Resistance and Pharmacologic Considerations of Dosing Newer Antifungal Therapies 116
Mucormycosis Caused by Unusual Mucormycetes, Non-Rhizopus, -Mucor, and -Lichtheimia Species 115
Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis 115
Importance of Pharmacokinetic Considerations for Selecting Therapy in the Treatment of Invasive Fungal Infections 114
Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study 114
Effect of preexposure to triazoles on susceptibility and virulence of Rhizopus oryzae 114
How Does Antifungal Pharmacology Differ for Mucormycosis Versus Aspergillosis? 114
Future Directions in Mucormycosis Research 113
Using carbapenems for carbapenem-resistant Klebsiella pneumoniae-Are we flogging a dead (work)horse antibiotic? 113
Radiologic findings of Fusarium pneumonia in neutropenic patients 112
Impaired bactericidal but not fungicidal activity of polymorphonuclear neutrophils in patients with chronic lymphocytic leukemia 111
Weekly liposomal amphotericin B as secondary prophylaxis for invasive fungal infections in patients with hematological malignancies 111
Drug interactions with voriconazole 110
Treatment of carbapenem-resistantKlebsiella pneumoniae: the state of the art 109
Totale 15.735
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.626
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.626
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021656 0 0 0 0 0 0 0 0 0 0 0 656
2021/20222.654 188 61 166 178 275 154 90 209 134 210 475 514
2022/20232.420 251 305 130 361 183 185 79 170 439 74 155 88
2023/2024761 67 129 46 64 67 137 108 18 17 42 45 21
2024/20252.696 105 575 212 239 384 175 184 74 37 132 117 462
2025/20267.248 855 474 655 489 722 415 764 472 1.443 526 266 167
Totale 22.635